(Review) Comprehensive review showing -MSH exerts broad anti-inflammatory effects (NF-B, cytokines, adhesion molecules), and highlights KPV as a non-pigmenting C-terminal tripeptide with therapeutic potential for skin and bowel inflammation and other immune-mediated conditions.
The STEP UP trial data provides the foundation for this approval
The published research summarized above is provided as scientific reference material
regulating the CoA to Acyl-CoA ratio (necessary for the production of ATP)
Goal: Maximize sperm production while on testosterone therapy Approach: HCG 500 IU subcutaneously every other day Consider adding FSH or HMG if response insufficient after 3 months Semen analysis at baseline, 3 months, and 6 months Timeline: Initial testosterone response: 2-4 weeks Sperm appearance: 3-4 months Significant count improvement: 4-6 months If conception remains the urgent priority, discontinuing TRT while increasing HCG to 3000 IU every other day accelerates recovery
Some studies suggest that GLP-1 receptor agonists like semaglutide can increase energy expenditure and fat oxidation
